Aclaris Therapeutics, Inc. ACRS
4.21 USD +0.31 (+7.95%)
Nov 9, 2026, 11:32 AM EST
3.85 Day range 4.28
2.10 52-week range 6.60
- YTD
- +39.87%
- 1 year
- +81.47%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 7.83M | 18.72M | 31.25M | 29.75M | 6.76M | |
| 7.83M | 18.72M | 31.25M | 29.75M | 6.76M | |
| 7.28M | 15.46M | 18.08M | 11.96M | 4.71M | |
| 542.00K | 3.26M | 13.17M | 17.79M | 2.05M | |
| 74.62M | 142.69M | 137.43M | 102.95M | 67.43M | |
| 52.65M | 33.59M | 98.38M | 77.81M | 43.81M | |
| 21.97M | 22.20M | 32.41M | 25.13M | 23.62M | |
| -74.08M | -139.43M | -124.26M | -85.15M | -65.38M | |
| -64.92M | -132.06M | -88.48M | -86.91M | -90.86M | |
| -64.92M | -132.06M | -88.48M | -86.91M | -90.86M | |
| -64.92M | -132.06M | -88.48M | -86.91M | -90.86M | |
| -64.92M | -132.06M | -88.48M | -86.91M | -90.86M | |
| -0.53 | -1.71 | -1.27 | -1.33 | -1.60 | |
| -0.53 | -1.71 | -1.27 | -1.33 | -1.60 | |
| -0.53 | -1.71 | -1.27 | -1.33 | -1.60 | |
| -64.92M | -132.06M | -88.85M | -86.91M | -90.86M | |
| -64.92M | -132.06M | -88.85M | -86.91M | -90.86M | |
| 122.56M | 77.30M | 69.81M | 65.21M | 56.73M | |
| 122.56M | 77.30M | 69.81M | 65.21M | 56.73M |